6-39304074-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_031460.4(KCNK17):c.571C>T(p.Leu191Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,612,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031460.4 missense
Scores
Clinical Significance
Conservation
Publications
- heart conduction diseaseInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNK17 | ENST00000373231.9 | c.571C>T | p.Leu191Phe | missense_variant | Exon 4 of 5 | 1 | NM_031460.4 | ENSP00000362328.4 | ||
KCNK17 | ENST00000503878.1 | n.1039C>T | non_coding_transcript_exon_variant | Exon 3 of 3 | 1 | |||||
KCNK17 | ENST00000453413.2 | c.571C>T | p.Leu191Phe | missense_variant | Exon 4 of 6 | 5 | ENSP00000401271.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152130Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460786Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 726764 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152130Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74314 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.571C>T (p.L191F) alteration is located in exon 4 (coding exon 4) of the KCNK17 gene. This alteration results from a C to T substitution at nucleotide position 571, causing the leucine (L) at amino acid position 191 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at